Over 20% of hospitalised COVID-19 patients have diabetes

“This manuscript provides guidance for healthcare providers caring for patients hospitalised for COVID-19 who also have a prior history of diabetes or who have high blood sugar levels at the time of hospitalisation,” said lead author Mary T. Korytkowski, M.D.,

GPs can reverse type 2 diabetes

Nearly half the people with type 2 diabetes who lost weight as part of a trial in primary care did not have the disease a year later.

Experts look beyond BMI to define what’s healthy

For over 200 years, medical professionals have used the simple weight-to-height ratio known as body mass index (BMI) as a tool to determine the overall health status of an individual.

New link identified between inflammation and depression in type-1 diabetes

Depression in type-1 diabetes patients is associated with higher levels of the inflammatory protein galectin-3, according to research published in the UK-based Society for Endocrinology’s Endocrine Connections. These findings suggest that galectin-3 levels may be

Reducing hypoglycaemia: Real-world findings

The debate relates to the lower limit of HbA1c which should be targeted. On the one hand, all available evidence suggests that in order to protect against microvascular complications an HbA1c below 7% should be

Diabetes treatment goals still suboptimal

A disease that is associated with significant comorbidities that contribute to an increased risk of costly hospitalisations; the logical response is to radically change the approach to the prevention, diagnosis and treatment of this disease.

Diabetes and sport

He adds, however, that ad hoc exercise can cause havoc with blood glucose levels because it is difficult to know how much insulin to decrease or increase and how much of a snack one would

Ward off type 2 diabetes: embrace healthy living

“South Africa is fast becoming an overweight nation, and our rates of obesity among certain sections of the population are rivalling those recorded in the US. This corresponds with an increase in the incidence of

Placing diabetes management firmly on the table

“The diabetes tsunami is here. Unless we meet it head on with appropriate management, this condition is single-handedly set to break the health care system,   if not the entire economy, in the next decade.”

Lilly’s history of diabetes care

Lilly became the first company to manufacture this life-saving medicine on a large scale – making it widely available to people who so desperately needed it. In 1982, Lilly introduced another milestone in diabetes research:

Hidden faces of Diabetes

A range of thought-provoking topics were presented and lively Q&A sessions ensued. The scientific programme addressed many common challenges related to managing patients living with diabetes, with a special focus on painful peripheral neuropathy. The

The transition to insulin therapy

There are several reasons why a person would require insulin, even if it had not   been necessary before. Some patients may only need to take insulin for a short time to manage the impact